Opportunity Information: Apply for PAR 17 066
Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42) is a National Institutes of Health (NIH) funding opportunity from the National Institute on Aging (NIA) designed to support small businesses that are building new, practical technologies to improve the real-world clinical care and day-to-day management of Alzheimers disease and Alzheimers-disease-related dementias (AD/ADRD), including situations where AD occurs alongside other medical conditions. The opportunity is offered under the Small Business Technology Transfer (STTR) program, which is structured to encourage partnerships between an eligible small business and a research institution so that early-stage innovations can move toward products and services that are usable in clinical settings. The grant mechanism is listed as R41/R42, which corresponds to the STTR phased approach: Phase I (R41) typically supports feasibility and proof-of-concept work, while Phase II (R42) supports further development and refinement, with an emphasis on advancing toward commercialization and broader adoption.
The core purpose of the announcement is to drive the development of innovative tools that help clinicians, patients, caregivers, and health systems manage AD/ADRD more effectively. While the brief description does not list specific examples, the emphasis on "clinical care and management" generally points to applied technologies rather than basic science alone. In practice, projects under this theme often include solutions such as clinical decision support tools, digital health platforms, care coordination systems, remote monitoring approaches, caregiver support technologies, symptom tracking and management tools, or other scalable products that can improve assessment, treatment planning, safety, adherence, and ongoing management. The mention of comorbidities signals that NIA is interested not only in dementia-specific needs, but also in technologies that address the complexities of caring for people who have dementia plus other chronic conditions, which can complicate medication management, care planning, and outcomes.
Eligibility is limited to small businesses, consistent with the STTR program requirements, and the announcement clearly restricts non-U.S. participation in key ways. Non-domestic (non-U.S.) entities (foreign institutions) cannot apply as the primary applicant, and non-domestic components of U.S. organizations are not eligible to apply. However, "foreign components" may be allowed under NIH policy, meaning certain parts of the work could potentially be performed outside the United States if they meet NIH rules and are justified, but the applicant organization itself must be an eligible U.S. small business and must follow NIH Grants Policy Statement guidance on what qualifies as an allowable foreign component.
Administratively, this opportunity is categorized as a discretionary grant in the health area and is associated with CFDA number 93.866. The funding opportunity number is PAR 17-066, and the opportunity title indicates it is specifically aligned with tools for clinical care and management rather than discovery research. The source data lists an original closing date of 2019-09-05, and it does not specify an award ceiling or expected number of awards in the provided excerpt, which suggests applicants would need to refer to the full FOA text for current budget limits, project periods, phase-specific caps, and other detailed submission and review requirements. The posting creation date is 2016-12-02, indicating when the announcement record was originally created.
Overall, the opportunity is aimed at accelerating practical, innovative care-management technologies for AD/ADRD through the STTR model, supporting small businesses that can combine product-focused development with research collaboration, while keeping eligibility centered on U.S.-based small business applicants and NIH-compliant arrangements for any allowable foreign components.Apply for PAR 17 066
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2016-12-02.
- Applicants must submit their applications by 2019-09-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the "Tools for Clinical Care and Management of Alzheimer's Disease (AD) and Its Comorbidities (R41/R42)" opportunity?
It is a National Institutes of Health (NIH) funding opportunity from the National Institute on Aging (NIA) intended to support small businesses developing new, practical technologies that improve real-world clinical care and day-to-day management of Alzheimer's disease and Alzheimer's-disease-related dementias (AD/ADRD), including cases where dementia occurs alongside other medical conditions (comorbidities).
Which agency and institute sponsor this grant opportunity?
The opportunity is sponsored by the NIH, specifically through the National Institute on Aging (NIA).
What program is this opportunity offered under?
This opportunity is offered under the Small Business Technology Transfer (STTR) program, which is designed to encourage partnerships between an eligible small business and a research institution so early-stage innovations can move toward usable products and services in clinical settings.
What do the grant mechanisms R41 and R42 mean?
R41 and R42 refer to the STTR phased approach. Phase I (R41) typically supports feasibility and proof-of-concept work. Phase II (R42) typically supports further development and refinement, with emphasis on advancing toward commercialization and broader adoption.
What is the main purpose of this funding opportunity?
The core purpose is to drive development of innovative tools that help clinicians, patients, caregivers, and health systems manage AD/ADRD more effectively, with a focus on applied technologies that improve real-world care and management rather than basic science alone.
What types of projects or tools does this opportunity generally support?
The description emphasizes "clinical care and management," which generally points to applied technologies. Examples commonly aligned with this theme can include clinical decision support tools, digital health platforms, care coordination systems, remote monitoring approaches, caregiver support technologies, symptom tracking and management tools, or other scalable products aimed at improving assessment, treatment planning, safety, adherence, and ongoing management.
How does the opportunity address Alzheimer's disease comorbidities?
The mention of comorbidities indicates interest in technologies that address the complexities of caring for people who have dementia plus other chronic conditions, which may complicate medication management, care planning, and outcomes.
Who is eligible to apply?
Eligibility is limited to small businesses, consistent with STTR program requirements.
Can a non-U.S. organization apply as the primary applicant?
No. Non-domestic (non-U.S.) entities (foreign institutions) cannot apply as the primary applicant.
Are non-domestic components of U.S. organizations eligible to apply?
No. Non-domestic components of U.S. organizations are not eligible to apply.
Are any parts of the project allowed to take place outside the United States?
Possibly. "Foreign components" may be allowed under NIH policy, meaning certain parts of the work could potentially be performed outside the U.S. if they meet NIH rules and are justified. The applicant organization must still be an eligible U.S. small business and must follow NIH Grants Policy Statement guidance on allowable foreign components.
What kind of grant is this categorized as?
It is categorized as a discretionary grant in the health area.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.866.
What is the funding opportunity number?
The funding opportunity number is PAR 17-066.
Does the provided information list the award ceiling or number of expected awards?
No. The provided excerpt does not specify an award ceiling or the expected number of awards. Applicants would need to consult the full Funding Opportunity Announcement (FOA) text for current budget limits, project periods, phase-specific caps, and detailed submission and review requirements.
What is the closing date shown in the provided information?
The source data lists an original closing date of 2019-09-05.
When was this announcement record originally created?
The posting creation date is 2016-12-02.
Is this opportunity aimed at basic discovery research or practical care tools?
Based on the title and description, it is specifically aligned with tools for clinical care and management, suggesting an emphasis on practical, applied care-management technologies rather than discovery research alone.
What is the intended impact of funding projects under this opportunity?
The stated intent is to accelerate practical, innovative care-management technologies for AD/ADRD through the STTR model by supporting small businesses that combine product-focused development with research collaboration, with an eye toward clinical usability, commercialization, and broader adoption.
Browse more opportunities from the same category: Health
Next opportunity: Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01)
Previous opportunity: Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R21)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 17 066
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 17 066) also looked into and applied for these:
| Funding Opportunity |
|---|
| Tools for Clinical Care and Management of Alzheimers Disease (AD) and its Comorbidities (R43/R44) Apply for PAR 17 067 Funding Number: PAR 17 067 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Clinical Trials Targeting HIV-1 Reservoirs in Children (U01) Apply for RFA AI 16 086 Funding Number: RFA AI 16 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Access to Research Careers Undergraduate - Student Training in Academic Research (MARC U-STAR) (T34) Apply for PAR 17 068 Funding Number: PAR 17 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV and AIDS Community Grants Program Apply for COMMGRANTSHIVAIDS17 Funding Number: COMMGRANTSHIVAIDS17 Agency: U.S. Mission to South Africa Category: Health Funding Amount: $50,000 |
| Institutional Training Programs to Advance Translational Research on Alzheimers Disease and AD Related Dementias (T32) Apply for RFA AG 17 063 Funding Number: RFA AG 17 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Programs to Enhance Research Training (IPERT) (R25) Apply for PAR 17 070 Funding Number: PAR 17 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Multipurpose Prevention Technologies: A Strategy for the Prevention of Sexually Transmitted Infections (STIs) (R61/R33) Apply for RFA AI 16 085 Funding Number: RFA AI 16 085 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Leveraging Electronic Health Records for Alcohol Services Research (R21/R33) Apply for PAR 17 071 Funding Number: PAR 17 071 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Centers in Minority Institutions (U54) Apply for RFA MD 17 003 Funding Number: RFA MD 17 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Frontotemporal Degeneration FTD Sequencing Consortium: Discovery, replication and validation (UG3/UH3) Apply for RFA NS 17 017 Funding Number: RFA NS 17 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Shared Instrumentation Grant (SIG) Program (S10) Apply for PAR 17 074 Funding Number: PAR 17 074 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Utilizing Health Information Technology to Scale and Spread Successful Practice Models Using Patient-reported Outcomes (R18) Apply for PA 17 077 Funding Number: PA 17 077 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $750,000 |
| Novel Analytical Approaches for Metabolomics Data (R03) Apply for RFA RM 17 001 Funding Number: RFA RM 17 001 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Innovations for Healthy Living - Improving Population Health and Eliminating Health Disparities (R43/R44) Apply for RFA MD 17 001 Funding Number: RFA MD 17 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 17 002 Funding Number: RFA MD 17 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34) Apply for RFA MH 17 612 Funding Number: RFA MH 17 612 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33) Apply for RFA MH 17 606 Funding Number: RFA MH 17 606 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10) Apply for PAR 17 076 Funding Number: PAR 17 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33) Apply for RFA MH 17 604 Funding Number: RFA MH 17 604 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01) Apply for PAR 17 079 Funding Number: PAR 17 079 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 066", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.